Unique Nano-Pulse Stimulation (NPS) Technology: Pulse Biosciences possesses a proprietary, non-thermal mechanism of action that precisely targets and ablates cells without causing significant damage to surrounding non-cellular tissue, differentiating it from conventional thermal ablation methods.

FDA Clearances and Market Access: The CellFX System has received regulatory clearances for specific dermatologic indications, providing a validated pathway for commercialization and demonstrating the technology's safety and efficacy.

Broad Therapeutic Pipeline Potential: The versatility of NPS suggests potential applications across multiple medical fields beyond dermatology, including oncology, drug delivery, and immunology, offering extensive long-term growth opportunities.